Skip to main content

Animations

MJFF Publications

2031 - 2040 of 7939 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: A novel risk calculator predicting surgical site infection after spinal surgery in patients with cerebral palsy
    Journal Name: Developmental Medicine & Child Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/dmcn.15193
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: The Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.810860
    Citation Count: 22
  • OPEN
    Title: NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation
    Journal Name: International Journal of Inflammation
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2022/2337363
    Citation Count: 5
  • OPEN
    Title: A Randomized, Double‐Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28970
    Citation Count: 24
  • OPEN
    Title: Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.015
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: Physician‐Assisted Dying: Access and Utilization in Patients with Movement Disorders
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28964
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28905
    Best OA location URL:
    Citation Count: 4
  • OPEN
    Title: CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.834580
    Citation Count: 23
  • RESTRICTED
    Title: Etiology, pathological characteristics, and clinical management of black pleural effusion
    Journal Name: Medicine
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1097/md.0000000000028130
    Citation Count: 6
  • OPEN
    Title: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2112712119
    Citation Count: 34
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.